Inceptor Bio has entered an agreement to acquire Arranta Bio’s 29,000 square foot process development and GMP clinical manufacturing facility and the transfer of a core operating team to establish cell therapy processes and clinical supply for Inceptor’s planned oncology clinical trials.   Inceptor Bio’s Advanced Manufacturing Platform (AMP+) will be based at the new facility in Gainesville, FL, that will be developed as a state-of-the-art cell and gene therapy GMP facility to deliver Ince...